Blog

■ Rheumatoid arthritis: Are psychological factors effective in disease flare?

Volkan Yılmaz, Ebru Umay, İbrahim Gündoğdu et al

Eur J Rheumatol. 2017 Jun; 4(2): 127–132

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473448/

 

■ Is male rheumatoid arthritis an occupational disease? A review

Dan Murphy, David Hutchinson

Open Rheumatol J. 2017; 11: 88–105

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585464/

 

■ Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?

Sarah Sacks, Alan Steuer

Eur J Rheumatol. 2017 Mar; 4(1): 57–58

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335888/

 

■ Is joint pain in patients with arthralgia suspicious for progressionto rheumatoid arthritis explained by subclinical inflammation? – A cross-seccional MRI-study

L.E. Burgers, R.M. ten Brinck, A.H.M. van der Helm-van Mil

Rheumatology (Oxford) 2019 Jan 1; 58(1): 86–93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319603/

 

■ From patients with arthralgia, pre-RA and recently diagnosed RA: What is the current status of understanding RA pathogenesis?

M Molendijk, H M W Hazes, E Lubberts

RMD Open 2018, vol 4 (1)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822638/

 

■ What is the additional value of MRI of the foot to the hand in undifferentiated arthritis to predict rheumatoid arthritis development?

1. J. Dakkak, D. M. Boeters, A. C. Boer et a

Arthritis Res Ther. 2019; 21: 56

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376768/

 

■ Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

1. F. Ten Cate, J. W. G. Jacobs, W. A. A. Swen et al

Arthritis Res Ther. 2018; 20: 15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791342/

 

■ Giant cell arteritis, polymyalgia rheumatic, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Cengiz Korkmaz, Pınar Yıldız

Eur J Rheumatol. 2017 Jun; 4(2): 157–160

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473456/

 

■ The rheumatoid hand in the light of fluorescence: a diagnostic technique of the future?

Paweł Żuchowski, Marzena Waszczak-Jeka, Szymon Kudlicki, Sławomir Jeka

Reumatologia. 2019; 57(1): 45–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409828/

 

■ Parasitoses intestinais: efeito protetor na artrite reumatoide?

Oliveira, Sandra Maximiano de et al.

Rev. Bras. Reumatol., Oct 2017, vol.57, no.5, p.461-465

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000500461&lng=pt&nrm=iso&tlng=pt (portuguese)

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000500461&lng=pt&nrm=iso&tlng=en (english)

 

■ A cluster of intracellular parasitic infections among patients on biological DMARDs – the tip of the iceberg

H Hammarström, L Dovetal, A Calander

Rheumatology Advances in Practice 2018, vol 2 (2)

https://academic.oup.com/rheumap/article/2/2/rky048/5220774

 

■ High prevalence of gallstone disease in rheumatoid arthrtitis: A new comorbidity related to dyslipidemia?

M C Garcia-Gómez, E de Lama, S Ordoñez-Palau et al

Reumatol Clin 2018, vol 14: 84-89

http://www.reumatologiaclinica.org/es-high-prevalence-gallstone-disease-in-articulo-S1699258X17301729

 

■ Qué papel juega la actividad de la enfermedad en el riesgo cardiovascular de la artrhritis rheumatoid?

M A R Huaranga, M D M Sánchez, M A Z D de la Espina et al

Reumatol Clin 2018, vol 14: 339-345

http://www.reumatologiaclinica.org/es-que-papel-juega-actividad-enfermedad-articulo-S1699258X17300839

 

■ Valor de la ecografia con Doppler de poder en pacients con arthritis reumatoide en remissión clínica: Reclassificación de la actividad de la enfermedad?

F Vergara, S Ruta, J Rosa et al

Reumatol Clin 2018, vol 14: 202-206

http://www.reumatologiaclinica.org/es-valor-ecografia-con-doppler-poder-articulo-S1699258X17300268

 

■ Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?

Yusuke Miwa, Hidekazu Furuya, Ryo Yanai et al

Eur J Rheumatol. 2018 Mar; 5(1): 22–26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895146/

 

■ Tumor-associated antigens in rheumatoid arthritis interstitial lung disease or malignancy

Gökhan SARGIN, Reyhan KÖSE, Taşkın ŞENTÜRK

Arch Rheumatol. 2018 Dec; 33(4): 431–437

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409176/

 

■ What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors

C A M Bouman, A A den Broeder, A van der Maas et al

RMD Open 2017, vol 3 (1)

https://rmdopen.bmj.com/content/3/1/e000327

 

■ Right drug, right patient, right time: Aspiration or future promise for biologics in rheumatoid arthritis?

Vasco C. Romão, Edward M. Vital, João Eurico Fonseca, Maya H. Buch

Arthritis Res Ther. 2017; 19: 239

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655983/

 

■ Terapia ocupacional na artrite reumatoide: o que o reumatologista precisa saber?

Almeida, Pedro Henrique Tavares Queiroz de et al.

Rev. Bras. Reumatol., Jun 2015, vol.55, no.3, p.272-280

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042015000300272&lng=pt&nrm=iso

 

■ Médico Responsável: Dr Paulo Fernando Leite

Cardiologia – CRMMG: 7026

Belo Horizonte/Minas Gerais/Brasil

Email: pfleite1873@gmail.com

■ Laboratory tests in Rheumatology: a rational approach

E Sureh

Cleveland Clinic Journal of Medicine 2019: vol 86 (3): 198-210

https://www.mdedge.com/ccjm/article/195311/rheumatology/laboratory-tests-rheumatology-rational-approach

 

■ Laboratory evaluation in rheumatic diseases

M Birtane, S Yavuz, N Tastekin

World J Methodol  2017, vol 7 (1): 1-8

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366934/

 

■ Rheumatoid fator as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis: results of a cohort study

Pedro Santos-Moreno, Guillermo Sánchez, Carlos Castro

Medicine (Baltimore) 2019 Feb; 98(5): e14181

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380754/

 

■ Feasibilty of cardiovascular disease risk assessments in rheumatology outpatient clinics: experinces from the nationwide NOCAR project

Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe et al

RMD Open. 2018; 4(2): e000737

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173264/

 

■ Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care

Denis Poddubnyy, Johanna Callhoff, Inge Spiller et al

RMD Open. 2018; 4(2): e000825

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336095/

 

■ Protocols on classification, monitoring and therapy in children´s rheumatology (PRO-KIND): results of the working group polyarticular juvenile idiopathic arthritis

Gerd Horneff, Ariane Klein, Gerd Ganser et

Pediatr Rheumatol Online J. 2017; 15: 78.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678777/

 

■ Assessment and management of musculoskeletal disorders among patient living with HIV

Dr Karen Walker-Bone, Dr Erin Doherty, et al

Rheumatology (Oxford). 2017 Oct 1; 56(10): 1648–1661

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483171/

 

■ How immunological profile drives clinical phenotype of primary Sjögren´s syndrome at diagnostic: analysis of 10500 patients (Sjögren Big Data Project)

Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, et al

Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):102-112

https://www.clinexprheumatol.org/article.asp?a=12899

 

■ Emerging technologies in autoantibody testing for rheumatic diseases

Nancy J. Olsen, May Y. Choi, Marvin J. Fritzler

Arthritis Res Ther. 2017; 19: 172

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525353/

 

■ Personalized medicine in rheumatology: the paradigm of serum autoantibodies

Sirotti S, Generali E, Ceribelli A, Isailovic N, De Santis M, Selmi C.

Auto Immun Highlights. 2017 Dec;8(1):10

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507804/

 

■ Are cytokines (IL-6, CRP and adiponectin) associated with bone mineral density in a young adult birth cohort?

Ana Maria Baptista Menezes, Paula Duarte Oliveira, Helen Gonçalves et al

BMC Musculoskelet Disord. 2018; 19: 427

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267914/

 

■ Ácidos graxos ômega-3, estado inflamatório e marcadores bioquímicos de pacientes com lúpus eritematoso sistêmico: estudo piloto

Borges, Mariane Curado et al

Rev. Bras. Reumatol., Dec 2017, vol.57, no.6, p.526-534

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000600526&lng=pt&nrm=iso&tlng=pt

 

■ Independência de isoformas de transferrina deficiente em carboidrato e peptídeos citrulinados cíclicos na artrite reumatoide

Gudowska, Monika et al

Rev. Bras. Reumatol., May 2017, vol.57, no.3, p.185-189

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000300185&lng=pt&nrm=iso&tlng=pt (Portuguese)

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000300185&lng=pt&nrm=iso&tlng=en (English)

 

■ Calprotectin in rheumatic diseases

Francesca Ometto, Lara Friso, Davide Astorri et al

Exp Biol Med (Maywood) 2017 Apr; 242(8): 859–873

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407536/

 

■ EULAR/ACR Classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai et al

the International Myositis Classification Criteria Project consortium, the Euromyositis register, the Juvenile dermatomyositis cohort biomarker study and repository (JDRG) (United Kingdom and Ireland)

Ann Rheum Dis. 2017 Dec; 76(12): 1955–1964

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736307/

 

■ Detecção de anticorpos antinucleares por imunofluorescência indireta em células HEp-2: definindo a diluição de triagem adequada para o diagnóstico das doenças reumáticas autoimunes.

Brito, Fabiano de Almeida et al.

Rev. Bras. Reumatol., Fev 2014, vol.54, no.1, p.13-20

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042014000100013&lng=pt&nrm=iso

 

■ Febre reumática: atualização dos critérios de Jones à luz da revisão da American Heart Association – 2015

Pereira, Breno Álvares de Faria, Belo, Alinne Rodrigues and Silva, Nilzio Antônio da

Rev. Bras. Reumatol., Aug 2017, vol.57, no.4, p.364-368

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000400364&lng=pt&nrm=iso&tlng=pt (portuguese)

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000400364&lng=pt&nrm=iso&tlng=en (english)

 

■ Acute rheumatic fever and rheumatic heart disease

Jonathan R. Carapetis, Andrea Beaton, Madeleine W. Cunningham et al

Nat Rev Dis Primers. 2016 Jan 14; 2: 15084

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810582/

 

■ Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines

Busger Op Vollenbroek FTM, Doggen CJM, et a

PLoS One. 2018 Mar 23;13(3):e0194401

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865732/

 

■ Autoantibodies in juvenile-onset myositis: their diagnostic value in and associated clinical phenotype in a large UK cohort

Tansley SL, Simou S, Shaddick G et al

J Autoimmun. 2017 Nov;84:55-64

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656106/

 

■ Biomarkers to guide clinical therapeutics in rheumatology?

William H. Robinson, Rong Mao

Curr Opin Rheumatol. 2016 Mar; 28(2): 168–175

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770786/

 

■ Serum markers in rheumatology arthritis: a longitudinal study of patients undergoing infliximab treatment

O Selaas, H H Nordal, A Halse et al

Int J Rheumatol 2015, 2015: 276815

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695666/

 

■ Gout: an old disease in new perspctive – a review

Gaafar Ragab, Mohsen Elshahaly, Thomas Bardin

J Adv Res. 2017 Sep; 8(5): 495–511

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512152/

 

■ Gout classification criteria: update and implications

Ana Beatriz Vargas-Santos, William J. Taylor, Tuhina Neogi

Curr Rheumatol Rep. 2016 Jul; 18(7): 46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981244/

 

■ 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Tuhina Neogi, Tim L Th A Jansen, Nicola Dalbeth et al

Ann Rheum Dis. 2015 Oct; 74(10): 1789–1798

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602275/

 

■ Systemic lúpus erythematosus biomarkers: the challeging guest

Cristina Arriens, Jonathan D. Wren, Melissa E. Munroe, Chandra Mohan

Rheumatology (Oxford) 2017 Apr; 56(Suppl 1): i32–i45

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850341/

 

■ Biomarkers of (osteo) arthritis

Ali Mobasheri, Yves Henrotin

Biomarkers. 2015 Nov 17; 20(8): 513–518

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840279/

 

■ Biomarkers in connective tissue diseases

Neelakshi R. Jog, Judith A. James

J Allergy Clin Immunol. 2017 Dec; 140(6): 1473–1483

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819750/

 

■ IV Consenso Brasileiro para pesquisa de autoanticorpos em células HEp-2

Francescantonio, Paulo Luiz Carvalho et al

Rev. Bras. Reumatol., Fev 2014, vol.54, no.1, p.44-50

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042014000100044&lng=pt&nrm=iso

 

■ Clinical and serological features of patients referred through a Rheumatology triags system because antinuclear antibodies

Christie Fitch-Rogalsky, Whitney Steber, Michael Mahler et al

PLoS One. 2014; 9(4): e93812.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976309/

 

■ Rheumatoid arthritis disease activity measures

American College of Rheumatolology Recommendations for use in clinical practice

J Anderson, L Caplan, J Yazdany et al

Arthritis Care Res (Hoboken). 2012 May; 64(5): 640–647

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028066/

 

■ Análise crítica do teste de anticorpos antinúcleo (FAn) na prática clínica

Dellavance, Alessandra, Leser, Paulo Guilherme and Andrade, Luís Eduardo Coelho

Rev. Bras. Reumatol., Ago 2007, vol.47, no.4, p.265-275

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042007000400005&lng=pt&nrm=iso

 

■ Valor diagnóstico do anticorpo antipeptídeo citrulinado cíclico na artrite reumatoide

Silva, Aldifran Ferreira da et al.

Rev. Bras. Reumatol., Jun 2006, vol.46, no.3, p.174-180.

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042006000300003&lng=pt&nrm=iso

 

■ Dosagem sérica de adenosina deaminase em lúpus eritematoso sistêmico: ausência de associação com atividade de doença.

Lima, Isabella, Néri, Fátima and Barreto Santiago, Mittermayer

Rev. Bras. Reumatol., Out 2005, vol.45, no.5, p.273-279

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042005000500002&lng=pt&nrm=iso

 

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

tel 40204020

CRMMG: 7026

Email: pfleite1873@gmail.com